Stage III Prostate Cancer AJCC v7 Active Not Recruiting Phase 2 Trials for Indometacin (DB00328)

IndicationStatusPhase
DBCOND0093329 (Stage III Prostate Cancer AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02849990A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomyTreatment